Nordic Capital sells Nycomed to an international investor group  

The sale of Nycomed is Denmark's second biggest acquisition deal this year, with a reported price tag of DKK 7.4 billion

The Nordic pharmaceutical company Nycomed, which has its headquarters in Denmark, has been sold by its current owner Nordic Capital to a group of international investors led by Credit Suisse First Boston's venture company CSFB Private Equity. The reported price tag is DKK 7.4 billion (USD 962 million). The deal is the second largest in Denmark this year, surpassed only by Microsoft's acquisition of software house Navision for DKK 10.8 billion (USD 1.4 billion). The news is reported in Jyllands-Posten today.


The venture company Nordic Capital acquired a majority of the shares in Nycomed from Amersham plc in May 1999, and then acquired Amersham’s remaining shareholding in 2001. Between 1999 and 2001, Nycomed has shown sustained revenue growth in excess of 15% annually, adjusted for terminated or divested businesses. EBITDA (earnings before interest, taxes, depreciations and amortisation) from the underlying operations has grown by more than 25% on a yearly basis.

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×